Generate Biomedicines, Inc. Announces Pricing of Initial Public Offering
SOMERVILLE, Mass., Feb. 26, 2026 /PRNewswire/ -- Generate Biomedicines, Inc. (Nasdaq: GENB) ("Generate"), a clinical-stage generative biology company pioneering the...
Read moreDetails